Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele Semaan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
Wealth, Health Expenditure, and Cancer: A National PerspectiveJad Chahoud, Adele Semaan, Alyssa Rieber
Heart & Lung : the Journal of Critical Care|February 18, 2015
Ventilator-associated events prevention, learning lessons from the past: A systematic reviewJad Chahoud, Adele Semaan, Khalid F Almoosa
Le Journal Medical Libanais. the Lebanese Medical Journal|July 14, 2015
PREVALENCE OF DIABETES MELLITUS AMONG PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSIONJad Chahoud, Jad Mrad, Adele Semaan, et al.
The International Journal of Health Planning and Management|August 4, 2012
Strategic planning processes and financial performance among hospitals in LebanonShadi Saleh, Amer Kaissi, Adele Semaan, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|September 16, 2016
Collaborative Learning in the Texas Medicaid 1115 Waiver ProgramLee Revere, Adele Semaan, Nicole Lievsay, et al.
JAMA Dermatology|January 1, 2016
Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysisJad Chahoud, Adele Semaan, Yong Chen, et al.
Journal of the National Cancer Institute|November 4, 2020
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic ReviewHoussein Safa, Monica Tamil, Philippe E Spiess, et al.
Clinical Genitourinary Cancer|January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed OpportunityJuskaran Chadha, Jacob J Adashek, Heather Jim, et al.
Eclinicalmedicine|January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisMahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
JCO Clinical Cancer Informatics|July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint InhibitorsGabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
Wealth, Health Expenditure, and Cancer: A National PerspectiveJad Chahoud, Adele Semaan, Alyssa Rieber
Heart & Lung : the Journal of Critical Care|February 18, 2015
Ventilator-associated events prevention, learning lessons from the past: A systematic reviewJad Chahoud, Adele Semaan, Khalid F Almoosa
Le Journal Medical Libanais. the Lebanese Medical Journal|July 14, 2015
PREVALENCE OF DIABETES MELLITUS AMONG PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSIONJad Chahoud, Jad Mrad, Adele Semaan, et al.
The International Journal of Health Planning and Management|August 4, 2012
Strategic planning processes and financial performance among hospitals in LebanonShadi Saleh, Amer Kaissi, Adele Semaan, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|September 16, 2016
Collaborative Learning in the Texas Medicaid 1115 Waiver ProgramLee Revere, Adele Semaan, Nicole Lievsay, et al.
JAMA Dermatology|January 1, 2016
Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysisJad Chahoud, Adele Semaan, Yong Chen, et al.
Journal of the National Cancer Institute|November 4, 2020
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic ReviewHoussein Safa, Monica Tamil, Philippe E Spiess, et al.
Clinical Genitourinary Cancer|January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed OpportunityJuskaran Chadha, Jacob J Adashek, Heather Jim, et al.
Eclinicalmedicine|January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisMahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
JCO Clinical Cancer Informatics|July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint InhibitorsGabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Pageof 2